Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 146-153 , May 2007

Age-Related Structural and Functional Changes in the Breast: Multimodality Correlation With Digital Mammography, Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography

References 

  1. Byng JW. Analysis of mammographic density and breast cancer risk from digitized mammograms. RadioGraphics. 1998;18:1587–1598
  2. Madabhushi A, Udupa JK, Souza A. Generalized scale: Theory, algorithms, and application to image inhomogeneity correction. Computer Vision and Image Understanding. 2006;101:100–121
  3. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensitynonuniformity in MRI data. Med Imaging IEEE Trans. 1998;17:87–97
  4. Falcao AX, Udupa JK, Samarasekera S, et al. User-steered image segmentation paradigms: Live wire and live lane. Graphical Models Image Process. 1998;60:233–260
  5. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology. 1976;121:545–552
  6. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:1159
  7. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and Combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–175
  8. Stomper PC, D’Souza DJ, DiNitto PA, et al. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol. 1996;167:1261–1265
  9. Kopans DB. Bias in the medical journals: A commentary. AJR Am J Roentgenol. 2005;185:176–177
  10. Chow CK, Venzon D, Jones EC, et al. Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev. 2000;9:917–921
  11. Cotran RS, Kumar V, Robbins SL. The breast. In:  Cotran RS editors. Robbins: Pathologic basis of disease. (ed 5). Philadelphia: WB Saunders Company; 1994;p. 93
  12. Gertig DM, Stillman IE, Byrne C, et al. Association of age and reproductive factors with benign breast tissue composition 1. Cancer Epidemiol Biomarkers Prev. 1999;8:873–879
  13. Cunha GR, Hom YK. Role of mesenchymal-epithelial interactions in mammary gland development. J Mammary Gland Biol Neoplasia. 1996;1:21–35
  14. Stines J, Tristant H. The normal breast and its variations in mammography. Eur J Radiol. 2005;54:26–36
  15. Tanner JM. Growth at Adolescence: With a General Consideration of the Effects of Hereditary and Environmental Factors Upon Growth and Maturation From Birth to Maturity (ed 2). Oxford: Blackwell Scientific Publications; 1962;
  16. Russo J, Russo IH. Development of the human breast. Maturitas. 2004;49:2–15
  17. Russo J, Mills MJ, Moussalli MJ, et al. Influence of human breast development on the growth properties of primary cultures. In Vitro Cell Dev Biol. 1989;25:643–649
  18. Russo J, Reina D, Frederick J, et al. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res. 1988;48:2837–2857
  19. Russo J, Moral R, Balogh GA, et al. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005;7:131–142
  20. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev. 1994;3:353–364
  21. Soderqvist G, Isaksson E, von Schoultz B, et al. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol. 1997;176:123–128
  22. Graham SJ, Stanchev PL, Lloyd-Smith JO, et al. Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging. 1995;5:695–701
  23. White E, Velentgas P, Mandelson MT, et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst. 1998;90:906–910
  24. Muller-Schimpfle M, Ohmenhauser K, Stoll P, et al. Menstrual cycle and age: Influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203:145–149
  25. Anderson TJ. Pathological studies of apoptosis in the normal breast. Endocrine-Related Cancer. 1999;6:9–12
  26. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol. 1997;15:3201–3207
  27. Freedman M, San Martin J, O’Gorman J, et al. Digitized mammography: A clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. JNCI Cancer Spectrum. 2001;93:51–56
  28. Brisson J, Brisson B, Cote G, et al. Tamoxifen and mammographic breast densities 1. Cancer Epidemiol Biomarkers Prev. 2000;9:911–915
  29. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976;37:2486–2492
  30. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol. 1976;126:1130–1137
  31. Grove JS, Goodman MJ, Gilbert FI, et al. Factors associated with mammographic pattern. Br J Radiol. 1985;58:21–25
  32. Flook D, Gilhome RW, Harman J, et al. Changes in Wolfe mammographic patterns with aging. Br J Radiol. 1987;60:455–456
  33. van Gils CH, Otten JD, Verbeek AL, et al. Short communication: Breast parenchymal patterns and their changes with age. Br J Radiol. 1995;68:1133–1135
  34. Hart BL, Steinbock RT, Mettler FA, et al. Age and race related changes in mammographic parenchymal patterns. Cancer. 1989;63:2537–2539
  35. Harvey JA, Bovbjerg VE. quantitative assessment of mammographic breast density: Relationship with breast cancer risk. Radiology. 2004;230:29–41
  36. Blend R, Rideout DF, Kaizer L, et al. Parenchymal patterns of the breast defined by real time ultrasound. Eur J Cancer Prev. 1995;4:293–298
  37. Oza AM, Boyd NF. Mammographic parenchymal patterns: A marker of breast cancer risk. Epidemiol Rev. 1993;15:196–208
  38. College of Radiology. A Breast Imaging Reporting and Data System: BI-RADS Atlas. (ed 2). Reston, VA: American College of Radiology; 2003;
  39. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: A case-control study. AJR Am J Roentgenol. 1987;148:1087–1092
  40. Lee NA, Rusinek H, Weinreb J, et al. Fatty and fibroglandular tissue volumes in the breasts of women 20-83 years old: Comparison of X-ray mammography and computer-assisted MR imaging. AJR Am J Roentgenol. 1997;168:501–506
  41. Blend MJ, Pavel DG. Bone marrow imaging: A comparison study using a 99Tcm-sulphur colloid versus a new 99Tcm-microaggregated albumin. Nucl Med Commun. 1986;7:787–789
  42. Chen SC, Carton AK, Albert M, et al. Initial clinical experience with contrast-enhanced digital breast tomosynthesis. Acad Radiol. 2007;14:229–238
  43. Vranjesevic D, Schiepers C, Silverman DH, et al. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med. 2003;44:1238–1242
  44. Kerlikowske K, Miglioretti DL, Ballard-Barbash R, et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol. 2003;21:4314–4321
  45. Laya MB, Larson EB, Taplin SH, et al: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. JNCI Cancer Spectrum 88:643-649
  46. Powell KA, Obuchowski NA, Davros WJ, et al. Quantitative analysis of breast parenchymal density: correlation with women’s age. Acad Radiol. 1999;6:742–747
  47. Maskarinec G, Pagano I, Lurie G, et al. A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2006;15:732–739
  48. Heine JJ, Malhotra P. Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography (Part 2. Serial breast tissue change and related temporal influences). Acad Radiol. 2002;9:317–335
  49. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–1886
  50. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: Effects with time, age, and menopause status. JNCI Cancer Spectrum. 1995;87:1622–1629
  51. Spicer DV, Ursin G, Parisky YR, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994;86:431–436

PII: S0001-2998(07)00019-0

doi: 10.1053/j.semnuclmed.2007.01.003

Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 146-153 , May 2007

Article Tools

* Image Usage & Resolution